University of Utah
Salt Lake City, Utah, 84108, United States
NCT Number: NCT04759755
This study design will test biological and behavioral mechanisms in the cross-sectional analyses and determine the prospective effects of circadian alignment and sleep on changes in cardiometabolic risk factors.
Looking for future studies?
Notify Me18 year–60 year
All sexes
Observational
Salt Lake City, Utah, 84108, United States
The goal of this study is to determine how sleep and circadian rhythm alignment contribute to neurobehavioral and behavioral mechanisms of cardiometabolic risk. The investigators propose that circadian misalignment, which is more common among individuals with late sleep timing, leads to increased consumption of energy dense/prepared foods and to decreased insulin sensitivity. Short sleep duration and neurobehavioral measures (i.e. delay discounting) may moderate these associations, thus exacerbating cardiometabolic risk factors. There is evidence for a direct biological link between circadian misalignment and insulin resistance, and for a relationship that is mediated through changes in eating behaviors. Insulin resistance and increased caloric intake over time lead to increased BMI and body fat.
In this study, the investigators will conduct cross-sectional and longitudinal analyses to determine biological and behavioral mechanisms that link circadian alignment and sleep duration to changes in cardiometabolic risk over 1 year. This study will identify individual differences that predict risk for cardiometabolic disorders and suggest potential for sleep, circadian and neurobehavioral interventions to reduce cardiometabolic risk.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: Baseline
Measured by a frequently sampled IV glucose tolerance test
Time frame: 12 months
Healthy Eating Index will be calculated from the Automated Self-Assessment of 24 hour diet recall (ASA-24)
Time frame: Baseline
Measured by a 10 item adjusting delay discounting measure
Time frame: 12 months
Height and weight will be measured at screening and 1 year follow-up
Time frame: 12 months
HbA1c will be measured at screening and 12-month follow-up
University of Utah
Other
Circadian and Sleep Pathways to Cardiometabolic Disease Risk: Role of Neurobehavioral Processes
Acronym: TIME
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT02075710
Body Weight, Nutrition Disorders
San Francisco, California, United States
View Trial DetailsNCT07717814
Body Weight, Nutrition Disorders
Anaheim, California, United States
View Trial DetailsNCT07313761
Body Weight, Nutrition Disorders
Anaheim, California, United States
View Trial DetailsNCT05330247
Body Weight, Diabetes Mellitus
Copenhagen, Copenhagen NV, Denmark
View Trial Details